Paulson Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$535K Sell
3,839
-48
-1% -$6.72K 0.13% 74
2025
Q4
$477K Buy
3,887
+67
+2% +$8.14K 0.11% 86
2025
Q3
$424K Buy
3,820
+581
+18% +$66K 0.1% 90
2025
Q2
$359K Sell
3,239
-76
-2% -$8.09K 0.09% 103
2025
Q1
$371K Hold
3,315
0.1% 91
2024
Q4
$306K Sell
3,315
-1,056
-24% -$95.1K 0.08% 109
2024
Q3
$366K Sell
4,371
-800
-15% -$61K 0.1% 105
2024
Q2
$355K Sell
5,171
-24
-0.5% -$1.6K 0.1% 102
2024
Q1
$381K Sell
5,195
-59
-1% -$4.54K 0.11% 96
2023
Q4
$426K Buy
5,254
+263
+5% +$20.5K 0.14% 82
2023
Q3
$374K Sell
4,991
-310
-6% -$23.8K 0.13% 84
2023
Q2
$409K Buy
5,301
+1,372
+35% +$109K 0.14% 79
2023
Q1
$326K Hold
3,929
0.14% 61
2022
Q4
$337K Sell
3,929
-2,100
-35% -$166K 0.16% 56
2022
Q3
$372K Buy
6,029
+757
+14% +$47.7K 0.2% 47
2022
Q2
$326K Buy
5,272
+524
+11% +$32.4K 0.17% 56
2022
Q1
$282K Buy
4,748
+423
+10% +$27K 0.13% 65
2021
Q4
$314K Buy
+4,325
New +$298K 0.14% 66
2020
Q3
Sell
-2,961
Closed -$228K 87
2020
Q2
$228K Buy
+2,961
New +$227K 0.16% 77
2018
Q1
Sell
-200
Closed -$14K 259
2017
Q4
$14K Buy
+200
New +$15.2K 0.01% 328

Other funds holding GILD

Paulson Wealth Management's GILD Position: Q1 2026 in Review

Paulson Wealth Management reduced its Gilead Sciences (GILD) stake by 1.2% in Q1 2026, selling an estimated $6.72K and leaving 3,839 shares worth $535K. The position accounts for 0.13% of the portfolio, ranked #74.

Paulson Wealth Management first reported a position in GILD in Q4 2017 and has held it in 20 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Paulson Wealth Management held 3,839 shares of Gilead Sciences worth $535K as of Q1 2026.
  • Paulson Wealth Management sold 48 Gilead Sciences shares in Q1 2026, an estimated $6.72K.
  • Gilead Sciences made up 0.13% of Paulson Wealth Management's portfolio in Q1 2026, its #74 holding.
  • Paulson Wealth Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 20 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Paulson Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.